BlackRock Portfolio holdings
AUM $5.23T
1-Year Return
24.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
This Quarter Return
+9.3%
1 Year Return
+24.48%
3 Year Return
+103%
5 Year Return
+187.44%
10 Year Return
+430.33%
AUM
$3.38T
AUM Growth
+$191B
(+6%)
Cap. Flow
-$3.43B
Cap. Flow
% of AUM
-0.1%
Top 10 Holdings %
Top 10 Hldgs %
19.49%
Holding
5,762
New
69
Increased
2,342
Reduced
2,465
Closed
253
Top Buys
| 1 |
GE HealthCare
GEHC
|
+$2.19B |
| 2 |
Microsoft
MSFT
|
+$1.59B |
| 3 |
Amazon
AMZN
|
+$1.33B |
| 4 |
NVIDIA
NVDA
|
+$1.07B |
| 5 |
Linde
LIN
|
+$984M |
Top Sells
| 1 |
GE Aerospace
GE
|
+$1.86B |
| 2 |
Exxon Mobil
XOM
|
+$1.45B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.1B |
| 4 |
SIVB
SVB Financial Group
SIVB
|
+$1.1B |
| 5 |
STOR
STORE Capital Corporation
STOR
|
+$936M |
Sector Composition
| 1 | Technology | 24.43% |
| 2 | Healthcare | 14.47% |
| 3 | Financials | 11.81% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICVX
3326
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $7.6M | ﹤0.01% |
1,310,363
-56,929
| -4% | -$330K |
|
3327
Greene County Bancorp
GCBC
$406M
| $7.59M | ﹤0.01% |
334,709
-19,807
| -6% | -$449K |
|
3328
ALX Oncology
ALXO
$56.2M
| $7.54M | ﹤0.01% |
1,668,624
-32,462
| -2% | -$147K |
|
|
AHT
3329
Ashford Hospitality Trust
AHT
$37.2M
| $7.53M | ﹤0.01% |
234,587
-20,272
| -8% | -$651K |
|
|
LX
3330
LexinFintech Holdings
LX
$968M
| $7.48M | ﹤0.01% |
2,758,616
+207,460
| +8% | +$562K |
|
3331
iShares MSCI Intl Value Factor ETF
IVLU
$2.64B
| $7.43M | ﹤0.01% |
299,652
-78,604
| -21% | -$1.95M |
|
3332
TaskUs
TASK
$1.56B
| $7.37M | ﹤0.01% |
510,444
-6,913
| -1% | -$99.8K |
|
3333
Goldman Sachs BDC
GSBD
$1.27B
| $7.34M | ﹤0.01% |
537,851
-218,467
| -29% | -$2.98M |
|
3334
EPR Properties 5.75% Series C Cumulative Convertible Preferred Shares
EPR.PRC
$139M
| $7.31M | ﹤0.01% |
410,834
+6,551
| +2% | +$117K |
|
3335
Applied Digital
APLD
$5.07B
| $7.31M | ﹤0.01% |
3,262,270
+392,767
| +14% | +$880K |
|
3336
ARS Pharmaceuticals
SPRY
$984M
| $7.28M | ﹤0.01% |
1,118,565
+215,020
| +24% | +$1.4M |
|
3337
TIM SA
TIMB
$10.3B
| $7.24M | ﹤0.01% |
586,046
-83,311
| -12% | -$1.03M |
|
|
TUP
3338
DELISTED
Tupperware Brands Corporation
TUP
| $7.23M | ﹤0.01% |
2,891,750
-242,770
| -8% | -$607K |
|
|
HOLI
3339
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $7.23M | ﹤0.01% |
416,941
+10,421
| +3% | +$181K |
|
3340
Innoviz Technologies
INVZ
$369M
| $7.2M | ﹤0.01% |
2,057,187
+121,696
| +6% | +$426K |
|
3341
Lifecore Biomedical
LFCR
$287M
| $7.17M | ﹤0.01% |
1,898,495
+50,342
| +3% | +$190K |
|
|
WE
3342
DELISTED
WeWork Inc.
WE
| $7.1M | ﹤0.01% |
228,364
+27,258
| +14% | +$848K |
|
3343
LXP Industrial Trust 6.5% Series C Cumulative Convertible Preferred Stock
LXP.PRC
$92.5M
| $7.1M | ﹤0.01% |
146,307
+622
| +0.4% | +$30.2K |
|
|
CMBT
3344
CMB.TECH NV
CMBT
$2.81B
| $7.09M | ﹤0.01% |
422,470
+379,844
| +891% | +$6.38M |
|
3345
Empire Petroleum
EP
$139M
| $7.03M | ﹤0.01% |
566,356
-2,845
| -0.5% | -$35.3K |
|
3346
Consumer Portfolio Services
CPSS
$192M
| $7.01M | ﹤0.01% |
656,133
-54,038
| -8% | -$578K |
|
3347
Bakkt Holdings
BKKT
$154M
| $7.01M | ﹤0.01% |
162,939
-6,125
| -4% | -$263K |
|
|
VNET
3348
VNET Group
VNET
$2.58B
| $6.99M | ﹤0.01% |
2,157,553
+65,407
| +3% | +$212K |
|
|
3349
EPR Properties 9.00% Series E Cumulative Convertible Preferred Shares
EPR.PRE
$109M
| $6.98M | ﹤0.01% |
264,029
+4,712
| +2% | +$125K |
|
|
VRNA
3350
Verona Pharma
VRNA
$9.2B
| $6.97M | ﹤0.01% |
347,226
+1,901
| +0.6% | +$38.2K |
|